Vizora日本語

Oncolys BioPharmaOncolys BioPharma Inc.4588東証グロース医薬品FY ending Dec 2025, non-consolidated, J-GAAP

Oncolys BioPharma FY ending Dec 2021 results

Oncolys BioPharma brought in ¥642.5M in revenue.

It lost about ¥226 for every ¥100 of sales at the operating level.

Revenue changed +104.5% from the prior year.

What changed from last year

FY ending Dec 2020 → FY ending Dec 2021

Revenue
+104.5%¥314.2M → ¥642.5M
Gross profit
-15.8%¥236.1M → ¥198.8M
Operating income
Loss-¥1.67B → -¥1.45B
Operating cash flow
Loss-¥1.47B → -¥1.74B
Free cash flow
Loss-¥1.47B → -¥1.74B

Where the money goes

FY ending Dec 2020 → FY ending Dec 2021

Where ¥100 of sales goes

For every ¥100 Oncolys BioPharma sells, how much goes where, and how much is kept.

FY ending Dec 2021
Cost of sales
¥69
SG&A
¥257
Operating loss
¥226
Net loss
¥251

Annual margin trends

Gross margin30.9%
FY ending Dec 2019: 91.3%91.3%FY ending Dec 2020: 75.2%75.2%FY ending Dec 2021: 30.9%30.9%FY19FY20FY21
Operating margin-226.4%
FY ending Dec 2019: -39.2%-39.2%FY ending Dec 2020: -533.0%-533.0%FY ending Dec 2021: -226.4%-226.4%FY19FY20FY21
Net margin-251.4%
FY ending Dec 2019: -70.0%-70.0%FY ending Dec 2020: -666.8%-666.8%FY ending Dec 2021: -251.4%-251.4%FY19FY20FY21

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Sources

Show source documents (6)

  • EDINET (FSA Japan)

    有価証券報告書－第22期(2025/01/01－2025/12/31)

    ID S100XTMG2026-03-25Open

  • EDINET (FSA Japan)

    有価証券報告書－第21期(2024/01/01－2024/12/31)

    ID S100VIBY2025-03-28Open

  • EDINET (FSA Japan)

    有価証券報告書－第20期(2023/01/01－2023/12/31)

    ID S100T65H2024-03-29Open

  • EDINET (FSA Japan)

    有価証券報告書－第19期(2022/01/01－2022/12/31)

    ID S100QI262023-03-30Open

  • EDINET (FSA Japan)

    訂正有価証券報告書－第18期(令和3年1月1日－令和3年12月31日)

    ID S100PNC22022-11-17Open

  • EDINET (FSA Japan)

    有価証券報告書－第17期(令和2年1月1日－令和2年12月31日)

    ID S100L1LQ2021-03-26Open

Extracted from XBRL: 40 / Derived from other figures: 2

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image